Despite highly effective treatment for hepatitis C virus (HCV) in the United States insurance coverage, age and race have been barriers to treatment, according to a new report from the CDC.
“Everyone with hepatitis C should have access to highly effective treatments to cure the infection, regardless of age, race or insurance status,” said Debra E. Houry, MD, MPH, the CDC’s acting principal deputy director and director of CDC’s National Center for Injury Prevention and